Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Charles Turck, PharmD, BCPS, BCCCP
Neeraj Agarwal, MD, FASCO
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Rishi Sekar, MD
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Zachery Reichert MD, PhD
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Jacob Sands, MD
Aakesh Desai, MD, MPH
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Jessica E. Hawley M.D. M.S.
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Neal Shore, MD, FACS
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Daniel Kwon, MD
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
An Exploration of Current and Emerging Therapies for mCRPC
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Filipa Lynce, MD
Inflammatory Breast Cancer: A New Scoring System Proposed
A Look at What’s New in Invasive Lobular Carcinoma
Pavani Chalasani, MD, MPH
Jason A. Mouabbi, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.